Navigation Links
BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even
Date:5/22/2008

BioElectronics President, CEO, and Chairman recaps recent investor

conference call

FREDERICK, Md., May 22 /PRNewswire-FirstCall/ -- Andrew Whelan, President and CEO of BioElectronics Corporation (Pink Sheets: BIEL), the developer of ActiPatch, an FDA-cleared, drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers pulsed electromagnetic therapy, today issued the following summary of its recent investor conference call, which was held in order to update investors on the substantial revenue ramp being realized by the company. This revenue growth, which is being generated by an expanding international distribution base and increased acceptance of ActiPatch within the US plastic surgery market, has resulted recent profitability on a monthly basis and is expected to continue throughout 2008 and into 2009.

The following is a summary of Andrew Whelan's comments during the conference call:

At BioElectronics we have recently completed a series of significant changes that are beginning to produce meaningful growth at the company. Over the past few quarters we have substantially changed the management team, introduced a significant number of new products, meaningfully altered our manufacturing methodology and almost completely overhauled our distribution strategy.

Sales Management Additions -- In the last half of 2007 and into 2008 we continued to fine tune our management team. The most significant additions were senior sales personnel to target both North America and Western Europe. We are very happy to have these two new senior sales executives onboard and we are already starting to see strong results from their efforts. We now have the right sales team in place to move us forward in 2008.

Manufacturing -- During 2007 we moved the bulk of our manufacturing to China, which has significantly reduced our costs. Due to this manufacturing change we are now able to produc
'/>"/>

SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. BioElectronics Announces Conference Call to Update Investors on Growth Initiatives
2. BioElectronics Corporation Receives Major Orders From Italian Distributor
3. BioElectronics Launches 1 Day Breast Augmentation Recovery Kit
4. BioElectronics Announces Canadian Retail Product Launch
5. BioElectronics Corporation Announces Distribution Agreement With TSS Medical of Italy
6. BioElectronics Corporation Announces Singapore and Malaysia Sales
7. Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine
8. Immunosyn Corporation Files 10-Q
9. CorVel Corporation Announces Earnings Release Webcast
10. Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
11. Baxa Corporation Wins Two Colorado BMA 2008 Gold Key Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
(Date:5/21/2015)... King of Prussia, PA (PRWEB) May 21, 2015 ... that Julia O’Neill has joined the firm as senior ... more than 30 years of experience in the management ... the vaccines, biologics, pharmaceutical and chemical industries. , “We’re ... enhance our longstanding capabilities in data analytics,” said Dr. ...
(Date:5/20/2015)...  Select Medical Corporation ("Select") (NYSE: SEM ... early termination of the waiting period under the ... amended, applicable to the acquisition of Concentra Inc. ... that Select has created with Welsh, Carson, Anderson & ... MJ Acquisition Corporation has signed a definitive purchase ...
(Date:5/20/2015)... May 20, 2015  Haemonetics Corporation (NYSE: HAE ... & CEO, will present at The Jefferies 2015 Global ... on June 1 st , 2015 at 8:30am Eastern ... Concannon,s presentation live via webcast at: http://wsw.com/webcast/jeff88/hae ... HAE ) is a global healthcare company dedicated ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... Good Start Genetics ,™ Inc., an innovative molecular diagnostics company ... today announced it completed the initial closing of a $14 ... existing investors OrbiMed Advisors , Safeguard Scientifics, Inc. ... Sciences . Proceeds from this financing will be used to ...
... Corporation (NASDAQ: LIFE ) will exhibit ... cancer research during the American Association of Cancer Research ... April 4, in Chicago, Illinois. In addition, several of ... "From basic discovery of biomarkers to validation of ...
... of physicists at UC Santa Barbara has seen the light, ... and low-frequency laser beams at a semiconductor, the researchers caused ... smashed back into the cores they left behind. This recollision ... the current issue of the science journal Nature . ...
Cached Biology Technology:Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 2Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 3Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 4Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 5Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 2Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 3Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 4Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 5UCSB Physicists mix 2 lasers to create light at many frequencies 2UCSB Physicists mix 2 lasers to create light at many frequencies 3
(Date:5/14/2015)... , May 14, 2015  Verificient ... identity verification and online remote proctoring, announced ... software-as-a-service (SaaS) company and creator of the ... of the two companies will benefit from ... Canvas. As a fully integrated ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/7/2015)... Fingerprint Cards (FPC) introduces ... FPC,s smallest touch fingerprint sensors to date.  ... integration on the backside of the phone, and ... to integrate touch fingerprint sensors in the OEMs, ... for module manufacturers to customize the look and ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
... the aid of a straightforward experiment, researchers have provided ... how ancient organic molecules came together to form the ... online this week in JBC , demonstrated how ... length. RNA, the single-stranded precursor to DNA, normally ...
... ON A new technology that could help physicians ... and potentially fatal complication called preeclampsia has been developed ... Health Research Institute of Lawson Health Research Institute. ... have changed levels in the placenta of women who ...
... Institute of Ultrasound in Medicine (AIUM) 2009 Annual Convention ... Marquis Hotel in New York City, New York, Thursday ... numbers indicate that 2009 will prove to be better ... regarded as the AIUM,s most successful convention in history. ...
Cached Biology News:New technology aims to reduce maternal and neonatal deaths 2AIUM to Host 2009 Annual Convention in New York 2
... Cell Cultures (ECACC) in conjunction with the ... of England, Bristol, UK, have produced standardised ... HER2, oestrogen and progresterone receptor assays. The ... formalin fixed, breast cancer cell lines; MDA-MD-361, ...
... When Ambion introduced the highly potent TURBO ... a new standard was set in DNA removal ... of DNase I that is much more efficient ... trace amounts of unwanted DNA. TURBO DNase binds ...
Lyophilized. Purity: ≥90% by electrophoresis. Reconstitute in 0.3% NaCl. Prepared from serum that has been shown by certified tests to be negative for HBsAg and for HIV and HCV antibodies. ...
PP2B-Abeta (C-20)...
Biology Products: